Abbott Laboratories v. Superior Court

CourtCalifornia Court of Appeal
DecidedJune 27, 2018
DocketD072577M
StatusPublished

This text of Abbott Laboratories v. Superior Court (Abbott Laboratories v. Superior Court) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Abbott Laboratories v. Superior Court, (Cal. Ct. App. 2018).

Opinion

Filed 6/27/18 (unmodified opn. attached) CERTIFIED FOR PUBLICATION

COURT OF APPEAL, FOURTH APPELLATE DISTRICT

DIVISION ONE

STATE OF CALIFORNIA

ABBOTT LABORATORIES et al., D072577

Petitioners, (Orange County Super. Ct. No. 30-2016-00879117-CU-BT-CXC) v.

THE SUPERIOR COURT OF ORANGE ORDER DENYING REHEARING, COUNTY, DENYING MOTION FOR JUDICIAL NOTICE, AND MODIFYING OPINION Respondent;

THE PEOPLE ex rel. TONY NO CHANGE IN JUDGMENT RACKAUCKAS, as District Attorney, etc.,

Real Party in Interest.

THE COURT:

The petition for rehearing is denied. Justices Huffman and O'Rourke concur in the

denial; Justice Dato would grant.

The motion for judicial notice is denied. The opinion is modified as follows: The number "1560" is changed to "1566" so

that the citation starting on line 5 of footnote 15 on page 33 now reads:

(People ex rel. Kennedy v Beaumont Investment, Ltd. (2003) 111 Cal.App.4th 102, 127-128, quoting People v Superior Court (Jayhill), supra, 9 Cal.3d at p. 288; see People ex rel. Harris v Sarpas (2014) 225 Cal.App.4th 1539, 1566.)

On page 1 of the dissent, the first and second paragraphs are deleted and inserted

with the following language to now read:

As an intermediate appellate court, our primary role is to review final decisions of the superior court for prejudicial error. We generally avoid broad legal policy pronouncements, leaving that to the Supreme Court and the Legislature. Sometimes policy considerations can play an important part in our decisions, but even then we take pains to assure that the policy questions are squarely presented by the facts of the case and necessary to the decision we are required to render.

I believe the majority's decision to entertain the writ petition in this case violates each of these salutary guidelines. The majority then compound this error by deciding the ill-framed legal issue in a manner that will materially impair the interests of California consumers by fundamentally altering the structure of consumer protection laws in this state. For these reasons, I respectfully dissent.

This modification does not change the judgment.

HUFFMAN, Acting P. J.

Copies to: All parties

2 Filed 5/31/18 (unmodified version) CERTIFIED FOR PUBLICATION

ABBOTT LABORATORIES et al.,

Petitioners,

v. D072577 THE SUPERIOR COURT OF ORANGE COUNTY, (Orange County Super. Ct. No. 30-2016-00879117-CU-BT-CXC) Respondent;

THE PEOPLE ex rel. TONY RACKAUCKAS, as District Attorney, etc.,

ORIGINAL PROCEEDINGS in mandate following denial of a motion to strike

under Code of Civil Procedure sections 435 and 436, Kim G. Dunning, Judge. Petition

granted.

Kirkland & Ellis and Michael John Shipley, Jay P. Lefkowitz, Adam T. Humann

and Yosef Mahmood for Petitioners Teva Pharmaceuticals USA, Inc., Duramed

Pharmaceuticals Sales Corp., Inc. and Barr Pharmaceuticals, Inc. Munger, Tolles & Olson and Jeffrey I. Weinberger, Stuart N. Senator and Blanca

F. Young for Petitioners AbbVie Inc. and Abbott Laboratories.

Horvitz & Levy and Jeremy Brooks Rosen, Stanley H. Chen, Janet Y. Galeria, for

Chamber of Commerce of the United States of America; Heather Lynn Wallace, for

California Chamber of Commerce as Amici Curiae on behalf of Petitioners.

Tony Rackauckas, Orange County District Attorney, Joseph D'Agostino, Assistant

District Attorney, Kelly A. Ernby, Deputy District Attorney; Robinson Calcagnie Inc. and

Mark P. Robinson, Jr., Kevin F. Calcagnie on behalf of Real Party in Interest.

Dennis J. Herrera, City Attorney, Yvonne R. Mere, Owen J. Clements, Deputy

City Attorneys, for the City and County of San Francisco; Michael Feuer, City Attorney,

Monica D. Castillo, Deputy City Attorney, for the City of Los Angeles; Mara W. Elliot,

City Attorney, Kathryn Turner, Kristine Lorenz, Deputy City Attorneys for the City of

San Diego; Richard Doyle, City Attorney, Nora Frimann, Assistant City Attorney for the

City of San Jose; James R. Williams, County Counsel, Greta S. Hansen, Danny Chou,

Assistants County Counsel, Laura S. Trice, Deputy County Counsel, for Santa Clara

County; Jennifer Henning for California State Association of Counties as Amici Curiae

on behalf of Real Party in Interest.

Law Office of Valerie T. McGinty and Valerie T. McGinty for Consumer

Attorneys of California as Amicus Curiae on behalf of Real Party in Interest.

Xavier Becerra, Attorney General, Nicklas A. Akers, Assistant Attorney General,

Michele R. Van Gelderen, Daniel A. Olivas and David A. Jones, Deputy Attorneys

General for California Attorney General as Amicus Curiae.

2 Mark Louis Zahner of the California District Attorneys Association and Thomas

Atlee Papageorge of the San Diego District Attorney's Office, for the California District

Attorneys Association as Amici Curiae.

The Orange County District Attorney (the District Attorney), representing "the

People of the State of California," sued petitioners Abbott Laboratories, AbbVie Inc.,

Teva Pharmaceuticals USA, Inc., Barr Pharmaceuticals, Inc., Duramed Pharmaceuticals,

Inc. and Duramed Pharmaceuticals Sales Corp., alleging generally that petitioners

engaged in a scheme to keep generic versions of a prescription drug off the market in

violation of California's Unfair Competition Law (UCL; Bus. & Prof. Code,1 § 17200 et

seq.). The District Attorney sought an injunction as well as civil penalties and restitution.

Petitioners unsuccessfully moved to strike portions of the operative complaint alleging

"claims for restitution and civil penalties based on conduct outside the territorial

jurisdiction of Orange County."

In this writ proceeding, petitioners ask us to resolve a single issue: whether section

17204 of the UCL "permit[s] a county district attorney to bring a claim that seeks relief

for alleged injuries to residents of California counties whom he or she does not represent,

based on conduct occurring outside the county he or she serves . . . ." Petitioners argue

district attorneys have no authority to prosecute civil actions absent specific legislative

authorization, and neither the Government Code, nor Business and Professions Code

1 Statutory references are to the Business and Professions Code unless otherwise specified. 3 section 17204, authorize the district attorney of a single county to seek statewide

penalties for alleged UCL violations. The California Attorney General has filed an

amicus brief on the question, as have the California District Attorneys Association; the

City Attorneys of Los Angeles, San Diego, San Francisco, and San Jose, Santa Clara

County Counsel, and California State Association of Counties (collectively the city

attorneys); the United States and California Chambers of Commerce (collectively

Chambers of Commerce); and the Consumer Attorneys of California.

We grant the petition. The California Constitution designates the Attorney

General the "chief law officer of the State" (Cal. Const., art. V, § 13), and consistent with

this constitutional provision, the Attorney General "has charge, as attorney, of all legal

matters in which the State is interested" (Gov. Code, § 12511) and also "shall . . .

prosecute or defend all causes to which the State . . . is a party in his or her official

capacity." (Gov. Code, § 12512.) The District Attorney, on the other hand, is a county

officer whose territorial jurisdiction and power is limited accordingly. Though section

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Aryeh v. Canon Business Solutions, Inc.
292 P.3d 871 (California Supreme Court, 2013)
Vandermost v. Bowen
269 P.3d 446 (California Supreme Court, 2012)
Sullivan v. Oracle Corp.
254 P.3d 237 (California Supreme Court, 2011)
Zhang v. Superior Court
304 P.3d 163 (California Supreme Court, 2013)
Candid Enterprises, Inc. v. Grossmont Union High School District
705 P.2d 876 (California Supreme Court, 1985)
Woodland Hills Residents Ass'n v. City Council of Los Angeles
593 P.2d 200 (California Supreme Court, 1979)
People v. Superior Court
507 P.2d 1400 (California Supreme Court, 1973)
Babb v. Superior Court
479 P.2d 379 (California Supreme Court, 1971)
Cortez v. Purolator Air Filtration Products Co.
999 P.2d 706 (California Supreme Court, 2000)
Kraus v. Trinity Management Services, Inc.
999 P.2d 718 (California Supreme Court, 2000)
City of Oakland v. Brock
67 P.2d 344 (California Supreme Court, 1937)
Robbins v. Superior Court
695 P.2d 695 (California Supreme Court, 1985)
Burden v. Snowden
828 P.2d 672 (California Supreme Court, 1992)
D'AMICO v. Board of Medical Examiners
520 P.2d 10 (California Supreme Court, 1974)
Pitts v. County of Kern
949 P.2d 920 (California Supreme Court, 1998)
Taylor v. Superior Court
598 P.2d 854 (California Supreme Court, 1979)
Collins v. Riley
152 P.2d 169 (California Supreme Court, 1944)
People v. Pacific Land Research Co.
569 P.2d 125 (California Supreme Court, 1977)
Avco Community Developers, Inc. v. South Coast Regional Commission
553 P.2d 546 (California Supreme Court, 1976)

Cite This Page — Counsel Stack

Bluebook (online)
Abbott Laboratories v. Superior Court, Counsel Stack Legal Research, https://law.counselstack.com/opinion/abbott-laboratories-v-superior-court-calctapp-2018.